Benjamin; Christopher D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Benjamin; Christopher D..The latest application filed is for "aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof".

Company Profile

0.14.14

Benjamin; Christopher D. - Beverly MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aglycosyl Anti-cd154 (cd40 Ligand) Antibodies And Uses Thereof App 20150017155 - Taylor; Frederick R. ; et al.	2015-01-15
Methods for inhibiting lymphotoxin-.beta. receptor signaling in TH1 cell-associated disorders Grant 8,455,445 - Browning , et al. June 4, 2	2013-06-04
Soluble Lymphotoxin-beta Receptor Fusion Protein And Methods For Inhibiting Lymphotoxin Beta-receptor Signaling App 20110250200 - BROWNING; Jeffrey L. ; et al.	2011-10-13
Soluble lymphotoxin-.beta. receptor fusion protein and methods for inhibiting lymphotoxin .beta.-receptor signaling Grant 7,951,371 - Browning , et al. May 31, 2	2011-05-31
Soluble Lymphotoxin-beta Receptor Fusion Protein And Methods For Inhibiting Lymphotoxin Beta-receptor Signaling App 20110046073 - Browning; Jeffrey L. ; et al.	2011-02-24
Anti-lymphotoxin-beta Receptor Antibodies As Anti-tumor Agents App 20090123421 - Browning; Jeffrey L. ; et al.	2009-05-14
Anti-lymphotoxin-.beta. receptor antibodies as anti-tumor agents Grant 7,459,537 - Browning , et al. December 2, 2	2008-12-02
Methods for inhibiting lymphotoxin .beta. receptor signalling Grant 7,427,403 - Browning , et al. September 23, 2	2008-09-23
Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof App 20080124278 - Taylor; Frederick R. ; et al.	2008-05-29
Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) App 20070149769 - Hession; Catherine A. ; et al.	2007-06-28
Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof App 20060193856 - Taylor; Frederick R. ; et al.	2006-08-31
Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins App 20060172346 - Zheng; Zhongli ; et al.	2006-08-03
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents Grant 7,001,598 - Browning , et al. February 21, 2	2006-02-21
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents App 20050281811 - Browning, Jeffrey L. ; et al.	2005-12-22
Methods for inhibiting lymphotoxin beta receptor signalling App 20050037003 - Browning, Jeffrey L. ; et al.	2005-02-17
Common gamma chain blocking agents Grant 6,770,745 - Burkly , et al. August 3, 2	2004-08-03
Soluble lymphotoxin-.beta. receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease Grant 6,669,941 - Browning , et al. December 30, 2	2003-12-30
Methods for designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins App 20030235861 - Zheng, Zhongli ; et al.	2003-12-25
Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) App 20030153731 - Hession, Catherine A. ; et al.	2003-08-14
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents App 20020090366 - Browning, Jeffrey L. ; et al.	2002-07-11
Soluble lymphotoxin-.beta. receptors as therapeutic agents for the treatment of immunological disease Grant 6,403,087 - Browning , et al. June 11, 2	2002-06-11
Common gamma chain blocking agents App 20020028202 - Burkly, Linda C. ; et al.	2002-03-07
Lymphotoxin-.alpha./.beta. complexes and anti-lympotoxin-.beta. receptor antibodies as anti-tumor agents Grant 6,312,691 - Browning , et al. November 6, 2	2001-11-06
VCAM fusion proteins and DNA coding therefor Grant 6,307,025 - Hession , et al. October 23, 2	2001-10-23
Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease Grant 5,925,351 - Browning , et al. July 20, 1	1999-07-20
Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) Grant 5,367,056 - Hession , et al. November 22, 1	1994-11-22
DNA sequences encoding vascular cell adhesion molecules (VCAMS) Grant 5,272,263 - Hession , et al. December 21, 1	1993-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.